Stock Scorecard



Stock Summary for Aurinia Pharmaceuticals Inc (AUPH) - $5.00 as of 3/28/2024 3:32:39 PM EST

Total Score

14 out of 29

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for AUPH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AUPH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AUPH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for AUPH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for AUPH

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors - Mirum Pharmaceuticals ( NASDAQ:MIRM ) , Century Therapeutics ( NASDAQ:IPSC ) 3/25/2024 11:00:00 AM
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair 2/22/2024 1:00:00 PM
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Analog Devices ( NASDAQ:ADI ) 2/22/2024 12:23:00 PM
Why Is Aurinia Pharmaceuticals Stock Trading Lower Today? - Aurinia Pharmaceuticals ( NASDAQ:AUPH ) 2/15/2024 2:51:00 PM
Aurinia Pharmaceuticals ( AUPH ) Reports Q4 Loss, Tops Revenue Estimates 2/15/2024 12:25:00 PM
Esperion Therapeutics ( ESPR ) Expected to Beat Earnings Estimates: Can the Stock Move Higher? 2/13/2024 3:00:00 PM
Aurinia Pharmaceuticals ( AUPH ) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release 2/8/2024 3:00:00 PM
Kane Biotech Announces Special Meeting of Shareholders 1/18/2024 9:30:00 PM
What's Going On With Aurinia Pharmaceuticals Stock? - Aurinia Pharmaceuticals ( NASDAQ:AUPH ) 1/5/2024 3:56:00 PM
Are Medical Stocks Lagging Aurinia Pharmaceuticals ( AUPH ) This Year? 12/28/2023 2:40:00 PM

Financial Details for AUPH

Company Overview

Ticker AUPH
Company Name Aurinia Pharmaceuticals Inc
Country USA
Description Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/2/2024

Stock Price History

Last Day Price 5.00
Last Day Price Updated 3/28/2024 3:32:39 PM EST
Last Day Volume 1,438,779
Average Daily Volume 2,810,185
52-Week High 12.43
52-Week Low 4.93
Last Price to 52 Week Low 1.42%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -14.57
Free Cash Flow Ratio 2.07
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 5.50
Total Cash Per Share 2.42
Book Value Per Share Most Recent Quarter 2.63
Price to Book Ratio 1.91
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 4.06
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 144,618,000
Market Capitalization 723,090,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 27.88%
Reported EPS 12 Trailing Months -0.54
Reported EPS Past Year -0.54
Reported EPS Prior Year -0.76
Net Income Twelve Trailing Months -78,020,000
Net Income Past Year -78,020,000
Net Income Prior Year -108,180,000
Quarterly Revenue Growth YOY 58.60%
5-Year Revenue Growth 226.86%

Balance Sheet

Total Cash Most Recent Quarter 350,369,000
Total Cash Past Year 350,369,000
Total Cash Prior Year 389,306,000
Net Cash Position Most Recent Quarter 350,369,000
Net Cash Position Past Year 350,369,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 377,954,000
Total Stockholder Equity Prior Year 405,435,000
Total Stockholder Equity Most Recent Quarter 377,954,000

Options

Put/Call Ratio 0.23
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.45
MACD Signal -0.50
20-Day Bollinger Lower Band 4.33
20-Day Bollinger Middle Band 7.48
20-Day Bollinger Upper Band 10.62
Beta 1.38
RSI 28.39
50-Day SMA 8.80
200-Day SMA 12.22

System

Modified 3/27/2024 6:28:00 PM EST